Latest Breaking News On - Society of neuro - Page 3 : comparemela.com

CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)

/PRNewswire/ CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel.

United statesSandra silbermanJohn climacoCompany on twitterUniversity of texas md anderson cancer centerSociety of neuroSociety for neuroPharmaceuticals fast track designationReata pharmaceuticals incPharmaceuticals incChief medical officerAnnual meetingReata pharmaceuticalsWaldemar priebeMedicinal chemistryFast track designation

CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)

CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSandra silbermanJohn climacoCompany on twitterUniversity of texas md anderson cancer centerSociety of neuroSociety for neuroExchange commissionPharmaceuticals fast track designationReata pharmaceuticals incSecurities exchangePharmaceuticals incChief medical officerAnnual meetingControlled trialDoxorubicin analog that effectively crosses

Midatech Pharma pleased with the progress made in H1 2022

Midatech Pharma pleased with the progress made in H1 2022

United statesMidatech kpisMidatech pharma plcCompanyq spheraSociety of neuroColumbia universityAmerican medical associationEuropean medicines agencyParent companyDuke universityPreston robert tisch brain tumor centerJanssen pharmaceuticaFast track designationOrphan medicine designationEuropean medicinesAntibody drug conjugates

ASTRO Issues Clinical Guideline on Radiation Therapy for IDH-Mutant Glioma

ASTRO’s first guideline for lower-grade glioma outlines best practices for patient-centered, multidisciplinary care

United statesHelena shihAmerican society of clinical oncologyWorld health organizationProton therapy centersRadiation oncology residency programEuropean society for radiotherapyAmerican association of neurological surgeons congressSociety of neuroCanadian association of radiation oncologyEye serviceAlvord brain tumor centerAmerican society for radiation oncologyZealand college of radiologistsUniversity of washingtonDepartment of radiation oncology at massachusetts

Plus Therapeutics, Inc (PSTV) CEO Dr Marc Hedrick on Q2 2022 Results - Earnings Call Transcript

Plus Therapeutics, Inc (PSTV) CEO Dr Marc Hedrick on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

France generalAndrew brennerNorman lafranceAndrew simsBill phillipsMichael rabinowitzMarc hedrickCompany participantsBiocept incEuropean society of medical oncologyNational cancer instituteNanoliposome development programSociety of neuroSociety for nuclear medicineExchange commissionMaxim group